This patent application describes a behavior disorder and obsessive-compulsive (OCD) and panic disorder (PD) treatment, comprising a therapeutically effective non-toxic dose of reboxetine and derivatives and or pharmaceutically acceptable salt thereof to a patient drugs.A·都比尼...
Neuropathy may be the most common complication of diabetes and can make walking difficult as well as leading to even more serious problems like losing a limb. Diabetic neuropathy is damage caused to the nerves, and it can result in numbness, tingling, burning, and pain. Until now the painkill...
Pregabalin (Lyrica) is indicated for the management of pain associated with diabetic neuropathy and postherpetic neuralgia. It also is indicated as adjunct... JL Thomas,RR Walker - 《American Family Physician》 被引量: 6发表: 2006年 Anticonvulsant Medications for Treatment of Neuropathic and "Functi...
Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain 138, 43–52 (2015). Article PubMed Google Scholar Cazzato, D. et al. Small fiber neuropathy is a common feature of Ehlers-Danlos syndromes. Neurology 87, 155–159 (2016). Article PubMed PubMed...
The invention further relates to the use of these compounds in the treatment of impaired glucose tolerance, glucosuria, hyperlipidemia, metabolic acidoses, diabetes mellitus, diabetic neuropathy and nephropathy as well as secondary diseases ... HU Demuth,K Glund,D Schlenzig,... - CA 被引量: ...
According to the Wuerzburg scientists, this study raises hopes of identifying a cause at least in some of thepatientssuffering from inflammatory neuropathies and that a simple blood test for autoantibodies might help them get targeted treatment. ...
New perspective on diabetic neuropathy pathogenesis and treatmentInpharma Weekly -doi:10.2165/00128413-199409320-00003NoneSpringer International PublishingInpharma Weekly
The present study examined the potential of Actovegin (Nycomed Pharma, Zurich, Switzerland), a hemoderivative from calf blood that contains low molecular weight products and stimulates oxygen absorption, utilization, and cellular energy metabolism in the treatment of symptomatic neuropathy. 展开 年份: ...
Thus, favipiravir shows excellent promise for the treatment of patients with the highly pathogenic H5N1 influenza. The National Institutes of Health of the US is currently conducting a Phase II, randomized, double-blind, placebo-controlled, multicenter (in 235 study locations) study evaluating the ...
Efgartigimod is also being studied for treatment of other autoimmune diseases such as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), myositis, pemphigus vulgaris, and primary immune thrombocytopenia (ITP). A real-world evidence study comparing efgartigimod to conventional therapy ...